CDXS · Codexis Inc
United States · RS rating 15 · As of 2026-11-03
| Price | 1.08 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 19 / 25 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 4 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +150.0% |
| Sales growth Q/Q | +352.4% |
| Distance from 52-week high | +62.1% |
| Market cap (USD) | $229.0M |